Jenburkt Pharmaceuticals share news, announcements and annual reports
NSE: JENBURPHBSE: 524731Pharmaceuticals & BiotechnologySmall Cap
Jenburkt Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1995
Last close ₹853.60down ₹18.70 (2.14%)BSE ₹854.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹872.30.
30 Oct: open ₹887.75, high ₹887.75, low ₹845.10
52-week range of BSE trades to 30 Oct 2026
₹848.35Low, 30 Oct 2026₹1,321.00High, 31 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹377 Cr1,871st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.47
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.43%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,49687.0% delivered
Jenburkt Pharmaceuticals board meetings
113 filed, newest first. Page 2 of 3.
May 2022
16 May · Board meeting
Meeting on 27 May 2022: audited results, final dividend and annual general meeting
Feb 2022
Jan 2022
31 Jan · Board meeting
Meeting on 11 Feb 2022: quarterly results
Oct 2021
14 Oct · Board meeting
Meeting on 26 Oct 2021: quarterly results
Aug 2021
2 Aug · Board meeting
Meeting on 12 Aug 2021: quarterly results
May 2021
24 May · Board meeting
Meeting on 2 Jun 2021: audited results and dividend
Jan 2021
25 Jan · Board meeting
Meeting on 5 Feb 2021: quarterly results
Oct 2020
22 Oct · Board meeting
Meeting on 30 Oct 2020: quarterly results
Jul 2020
27 Jul · Board meeting
Meeting on 4 Aug 2020: quarterly results
Jun 2020
19 Jun · Board meeting
Meeting on 30 Jun 2020: audited results
Mar 2020
17 Mar · Board meeting
Meeting on 28 Mar 20202 Mar · Board meeting
Meeting on 6 Mar 2020: interim dividend
Jan 2020
27 Jan · Board meeting
Meeting on 7 Feb 2020: quarterly results
Oct 2019
23 Oct · Board meeting
Meeting on 5 Nov 2019: audited results
Jul 2019
8 Jul · Board meeting
Meeting on 30 Jul 2019: quarterly results
May 2019
28 May · Board meeting
17 May · Board meeting
Meeting on 28 May 2019: audited results and final dividend
Jan 2019
25 Jan · Board meeting
Meeting on 5 Feb 2019: quarterly results
Oct 2018
May 2018
Mar 2018
Dec 2017
Sep 2017
May 2017